Insider Transactions in Q3 2023 at Pardes Biosciences, Inc. (PRDS)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 31
2023
|
James B. Tananbaum President and CEO |
BUY
Other acquisition or disposition
|
Indirect |
1,000
+50.0%
|
-
|
|
Aug 31
2023
|
James B. Tananbaum President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
16,813,146
-100.0%
|
-
|
|
Aug 31
2023
|
Michael David Varney Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
70,390
-100.0%
|
-
|
|
Aug 31
2023
|
Thomas G Wiggans Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
50,000
-100.0%
|
-
|
|
Aug 31
2023
|
J Jay Lobell Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,163,861
-100.0%
|
-
|
|
Aug 31
2023
|
J Jay Lobell Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
200,000
-100.0%
|
-
|
|
Aug 31
2023
|
Uri A Lopatin Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
351,948
-100.0%
|
-
|
|
Aug 31
2023
|
Uri A Lopatin Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,327,798
-100.0%
|
-
|
|
Aug 31
2023
|
Heidi Henson Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
316,753
-100.0%
|
-
|
|
Aug 31
2023
|
Elizabeth H. Lacy General Counsel, Secretary |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
211,169
-100.0%
|
-
|
|
Aug 31
2023
|
Mark Auerbach Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
70,390
-100.0%
|
-
|